IL-17A was shown to induce the production of vascular endothelial growth factor (VEGF)-A, VEGF-C, and VEGF-D that correlated with increased angiogenesis and lymphangiogenesis in NSCLC [23,36]. Here, IL17A is linked to non-small cell lung carcinoma.